Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and sclerotherapy technologies. These modalities have increasingly become the preferred firstline options over surgical stripping due to favorable safety profiles, strong clinical outcomes, and the expansion of officebased treatment settings.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for varicose vein treatment devices in the US from 2019 through 2034.
How will competitive dynamics among endovenous ablation, phlebectomy, and sclerotherapy evolve as adoption of minimally invasive treatments increases?
What is the market outlook for Varithena, the only available readytouse microfoam?
Nonthermal technologies are emerging.
How will emerging nonthermal, nontumescent devices, including innovations like Basis Medical’s Seclusion catheter, influence adoption patterns and competitive positioning?
How will established thermal ablation options (ELA and ERFA) compete against new nonthermal modalities as reimbursement and siteofservice dynamics evolve?
Table of contents
- Varicose Vein Treatment Devices - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Varicose Vein Treatment Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Varicose Vein Treatments, by Procedure Type, US, 2019u20132034
- Varicose Vein Treatments, by Technique, US, 2019u20132034
- Primary Varicose Vein Treatments, by Technique, US, 2019u20132034
- Adjunctive Varicose Vein Treatments, by Technique, US, 2019u20132034
- Varicose Vein Treatment Device Market, by Product Type, US (USD), 2019u20132034
- Market Shares
- Competitive Insights
- Market Developments
- Endovenous Ablation Device Market
- Surgical Stripping Device Market
- Powered Phlebectomy Device Market
- Sclerotherapy Agent Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Sclerotherapy Procedures, by Procedure Type, US, 2019u20132034
- Sclerotherapy Procedures, by Agent, US, 2019u20132034
- Sclerotherapy Procedures, by Technique, US, 2019u20132034
- Sclerotherapy Agent Market, by Procedure Type, US (USD), 2019u20132034
- Sclerotherapy Agent Market, by Agent, US (USD), 2019u20132034
- Sclerotherapy Agent Market, by Technique, US (USD), 2019u20132034
- Primary Treatment
- Adjunctive Treatment
- Spider Vein Treatment
- Market Shares
- Competitive Insights
- Appendix
